Viewing Study NCT03427060


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-01-06 @ 6:34 PM
Study NCT ID: NCT03427060
Status: COMPLETED
Last Update Posted: 2025-05-04
First Post: 2018-01-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Coversin in PNH in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Sponsor: AKARI Therapeutics
Organization: